IP
IndiaPulse

KHFM

SME Cap

KHFM Hospitality And Facility Management Services Ltd.

Consumer

KHFM Hospitality And Facility Management Services Ltd. operates in Hotels, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹60.9
+0.30 · +0.50%
Quote09 Jun, 10:02 am
Fundamentals09 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags24 Apr 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Weak fundamentals, management trust needs verification, price trend is neutral, and recent execution is mixed.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
OVERVALUED
26

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Weak Trust
54

low confidence · 0/0 claims checked

Technical
Neutral
48

Timing lens: price trend and sector relative strength.

Result consistency
mixed
63

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 30 Sept 2025

Bad · 0/100

Rev 0% YoY · PAT 0% YoY · margin compression · +14% QoQ

Filed 30 Sept 2025
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹57 Cr+0.0%+14.0%
EBITDA₹4 CrNDF-20.0%
Operating margin7.0%NDF-200 bps
PAT₹2 Cr+0.0%+100.0%
PAT margin3.5%NDF+151 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Issuer presentation review pending

KHFM Hospitality And Facility Management Services Ltd. operates in Hotels, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Sept 2025. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Technical timing lens

Trend score and candlestick chart

48Neutral

label neutral

Stock trend: 50
Sector RS: 45
Sector 3M: -0.7% vs Nifty +0.1%

Technical chart

KHFMweekly · 5Y-14.0%
Latest close ₹60.90 on 2026-06-09
Bar
+3.2%
RSI
50
MACD hist
1.47
52W pos
47%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹43₹53₹62₹71₹8052H52LVol2025-112026-012026-032026-052026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Neutral

Trend is undirectional — long-term trend unclear. RSI 50.

  • RSI(14) at 50 — falling, no extreme reading.
  • MACD above signal but histogram contracting — bullish momentum cooling.
  • 23% off 52W high · 35% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

26U-SCORE
OVERVALUED

Fundamental score breakdown

OVERVALUED
Valuation15/30
Growth10/25
Quality0/20
Balance Sheet6/15
Cash Flow0/10
Piotroski
5/9 (+3)
Penalties
-8
Raw sum
26

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

26/100 · OVERVALUED

Positive drivers

  • Fair-value margin of safety is positive at 47.2%.
  • Valuation contributes 15/30 to the score.
  • Growth contributes 10/25 to the score.

Main drags

  • Penalty bucket subtracts 8 points.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Cash flow is weaker at 0/10; verify the latest quarterly trend.
Sector valuation model

Healthcare valuation: PE/EVEBITDA with regulatory and pipeline checks

Healthcare valuation needs both earnings quality and regulatory/pipeline context.

Pharma PE/EVEBITDA
Primary lens
PE and EV/EBITDA adjusted for product mix and R&D/pipeline quality.
Secondary checks
USFDA risk, launch pipeline, margin trend, domestic vs export mix.
Main risk check
Regulatory setbacks or one-off product cycles can distort valuation.
PE
43.9
PB
2.2
EV/EBITDA
17.8
ROE
6.5%
ROCE
10.9%
FCF Yield
Debt/Equity
0.6
MoS
+47.2%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
26
Previous: 26
Verdict
OVERVALUED
Previous: OVERVALUED
Margin of safety
+47.2%
Previous: +47.5%

Score history

12 stored score snapshots. Latest stored move: +0 points.

08 Jun 2026
v4.2-nightly
19
19
26
26
26
26
19
20
26
26
26
26

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Trust Score
54Weak Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Weak Trust: Claim history is still being built. It ranks around the 13th percentile of the scored universe and 12th percentile within Consumer. Main check: cash conversion is weak at 28/100.

Mixed Trust Lite: Promoter pledge is zero. Key concern: Operating cash flow is negative at ₹-3 Cr.

Computed 22 May 2026
trust-lite-v1
0 docs indexed · 0 concall links
Score band
Weak Trust

Management or financial behaviour needs caution. Demand stronger valuation compensation.

Relative rank
13th percentile

overall median 67 · Consumer: 12th pctile, median 67 · SME: 11th pctile, median 65

Evidence depth
Financial-only

0 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Weak Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
28
weak · profit to cash conversion
Balance sheet
59
watch · leverage and solvency
Discipline
52
watch · capital discipline
Results
63
acceptable · quarterly consistency

Trust positives

  • Promoter pledge is zero.
  • OPM spread across recent quarters is 4%.

Trust risks

  • Operating cash flow is negative at ₹-3 Cr.
  • Only 1 years of positive FCF.
  • Interest coverage is 1.8x.
  • ROE is low at 6.5%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹30.54
-99.4% MoS
DCF Fair PE
78.0
DCF Fair Value
₹115.44
+47.2% MoS
PEG
3.85

Fundamentals

Valuation

P/E
43.90
P/B
2.17
EV/EBITDA
17.80
Market Cap
141.00Cr

Profitability

ROE
6.53%
ROCE
10.90%
ROA
2.61%
Dividend Y

Growth (CAGR)

Revenue 5Y
13.00%
EPS 5Y
13.00%
Revenue 3Y
9.00%
EPS 3Y
9.00%

Balance Sheet

Debt/Equity
0.61
Interest Coverage
1.80×
Altman Z
3.42
Book Value
28.00

Cash Flow

FCF Yield
FCF Positive Y
1/5
OCF
-3.00 Cr
EPS TTM
1.48

Shareholding

Promoter Hold
37.17%
Promoter Pledge
0.00%
Momentum 52W
35%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.